RK
Ravi Kumar Upputhalla
About Ravi Kumar Upputhalla
Data last updated:
Ravi Kumar Upputhalla is a Director at Celon Laboratories Private Limited (since 2025). The companies operate in Pharma, Infrastructure and Utilities and Real Estate and Construction. Celon Laboratories Private Limited reported revenue of ₹148 Cr (FY 2025). Earlier, Ravi Kumar Upputhalla was a Company Secretary at Hetero Drugs Limited (2018–2024) and Company Secretary at Valary Lab Private Limited (2022–2024) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jul 2025 | 2001 | ₹148 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Company Secretary | 03 Sep 2018 | 1993 | ₹3,324 Cr (FY 2025) | Active | |
| Company Secretary | 30 Jun 2022 | 2019 | ₹65.12 Cr (FY 2025) | Active | |
| Company Secretary | 01 Feb 2016 | 1997 | Active | ||
| Company Secretary | 11 Aug 2014 | 2011 | ₹59.64 Cr (FY 2025) | Active | |
| Company Secretary | 05 Aug 2016 | 2005 | ₹267 Cr (FY 2025) | Active | |
| Company Secretary | 02 Jul 2018 | 1989 | ₹16,537 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravi Kumar Upputhalla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Bhatia | 08074866 | Celon Laboratories Private Limited | Managing Director |
| Rashmi Agarwal | Celon Laboratories Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kumar Upputhalla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kumar Upputhalla
Ravi Kumar Upputhalla currently holds 1 directorship: Celon Laboratories Private Limited (Director, since 14 Jul 2025, revenue ₹148 Cr (FY 2025)).
Ravi Kumar Upputhalla was first appointed on 11 Aug 2014 as Company Secretary at Sew Krishnagar Baharampore Highways Limited. The most recent appointment on record is 14 Jul 2025 at Celon Laboratories Private Limited.
Ravi Kumar Upputhalla held 6 earlier board appointments: Hetero Drugs Limited (Company Secretary, 03 Sep 2018 to 17 Feb 2024); Valary Lab Private Limited (Company Secretary, 30 Jun 2022 to 17 Feb 2024); Sew Transportation Networks Limited (Company Secretary, 01 Feb 2016 to 09 Jul 2016); Sew Krishnagar Baharampore Highways Limited (Company Secretary, 11 Aug 2014 to 09 Jul 2016); Ncc Urban Infrastructure Limited (Company Secretary, 05 Aug 2016 to 21 Jun 2018); and 1 more.
The current boards of Ravi Kumar Upputhalla's companies include Ajay Bhatia (Celon Laboratories Private Limited), Rashmi Agarwal (Celon Laboratories Private Limited).